OCOM Revenue and Competitors

Orlando, FL USA

Location

N/A

Total Funding

Education

Industry

Estimated Revenue & Valuation

  • OCOM's estimated annual revenue is currently $5M per year.(i)
  • OCOM's estimated revenue per employee is $144,000

Employee Data

  • OCOM has 35 Employees.(i)
  • OCOM grew their employee count by 192% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.5M389%N/AN/A
#2
$17.6M981%N/AN/A
#3
$13.7M7636%N/AN/A
#4
$5.9M415%N/AN/A
#5
$8.3M519%N/AN/A
#6
$8.4M524%N/AN/A
#7
$6.9M4871%N/AN/A
#8
$81.5M3625%N/AN/A
#9
$1.8M17-26%N/AN/A
#10
$3.7M290%N/AN/A
Add Company

What Is OCOM?

The mission of the Orlando College of Osteopathic Medicine (OCOM) is to train caring and competent osteopathic physicians who will have an impact on the Central Florida community, our nation, and our global community.\n\nOCOM has been granted pre-accreditation status. Please note that OCOM is a unit of the Orlando Health Science University (OHSU), provisionally licensed by the Florida Commission on Independent Education (License Number 10184). The American Osteopathic Association Commission on Osteopathic Accreditation (COCA) may be contacted at predoc@osteopathic.org or COCA, c/o AOA 142 E. Ontario Street, Chicago, IL 60611. All other inquiries to OCOM may be forwarded to Robert T Hasty, DO, FACOI, FACP, Founding Dean and Chief Academic Officer at rhasty@ocom.org. It is the policy of Orlando Health Sciences University and the Proposed Orlando College of Osteopathic Medicine that there is no discrimination in the selection and treatment of administrative personnel, faculty and staff, and students based on race, ethnicity, color, sex, sexual orientation, gender, gender identity, national origin, age or disabilities, and religion.

keywords:N/A

N/A

Total Funding

35

Number of Employees

$5M

Revenue (est)

192%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.8M369%N/A
#2
$8.6M379%N/A
#3
$8.8M389%N/A
#4
$8.8M38-7%N/A
#5
$7.7M38-3%N/A